KYONGBO PHARMACEUTICAL Aktie

Kaufen
Verkaufen
8.050,00 KRW -10,00 KRW -0,12 %

KYONGBO PHARMACEUTICAL Umsatz, Kennzahlen, Bilanz/GuV

Um die angezeigten Werte im Chart zu ändern, klicken Sie bitte unten in der Tabelle die entsprechenden Werte an (max. 4 gleichzeitig)

KYONGBO PHARMACEUTICAL: Die Aktie (in KRW)

2025202420232022202120202019
8,00194,00124,0026,00-314,00393,00221,00
7,63194,06124,4225,54-313,52393,38221,08
7,63194,06124,4225,54-313,52393,38221,08
50,0050,0050,0050,0050,00100,00100,00
0,000,000,000,00-50,000,00-50,00
1.195,341.195,341.195,341.195,342.390,692.390,694.781,37

KYONGBO PHARMACEUTICAL: Unternehmenskennzahlen (in KRW)

2025202420232022202120202019
11.047,219.978,569.050,028.209,567.138,529.005,168.018,88
756,7132,0567,43391,54-41,5637,36
756,7132,0567,43391,54-41,5637,36
0,870,800,600,500,470,611,21
45,6151,4853,6659,1660,9260,6262,17
54,3948,5246,3440,8439,0839,3837,83

KYONGBO PHARMACEUTICAL: GuV (in Mio. KRW)

2025202420232022202120202019
264.104,06238.556,13216.357,48196.264,90170.659,65215.285,10191.706,19
10,7110,2610,2415,00-20,7312,30-4,79
97.822,8677.955,2958.886,6640.224,7733.133,8450.120,3437.641,91
25,4932,3846,3921,40-33,8933,15-26,57
3.518,5810.453,735.544,771.392,65-6.624,848.661,436.194,07
-66,3488,53298,14--39,83-64,13
-3.701,116.278,682.548,25-151,11-9.720,6114.251,527.049,94
-146,39-98,45-102,15-60,04
182,294.639,332.974,40610,59-7.495,189.404,455.285,24
-96,0755,98387,14--77,94-59,70

KYONGBO PHARMACEUTICAL: Bilanz (in Mio. KRW)

2025202420232022202120202019
173.800137.733124.69999.19093.467101.36490.759
1.110,60212,17269,26151,47194,62317,91290,47
145.738146.154144.381143.704145.701156.057149.164
-0,281,230,47-1,37-6,644,620,10
319.538283.887269.080242.894239.168257.421239.923
12,565,5010,781,56-7,097,298,26

KYONGBO PHARMACEUTICAL: sonstige Angaben (in KRW)

2025202420232022202120202019
-96,0755,98387,13--179,7077,94-59,70
-96,0755,98387,13--179,7077,94-59,70
571525514491481503494
8,762,144,682,08-4,371,829,78
Die Daten werden von FactSet zur Verfügung gestellt.
FactSet vereinheitlicht die Rechnungslegungsstandards IFRS und US-GAAP, um Unternehmenszahlen branchen- und länderübergreifend vergleichbar zu machen.